GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract HHSN272200900060CJANSSEN VACCINES & PREVENTION B.V.

Overview

Award facts

Net obligations
$48.59M
$48,585,370of $100.96M potential value
Period of performance
Sep 15, 2017 to Aug 14, 2014
Ended
Modifications
11
Latest action Sep 15, 2017
Contract type
Definitive contract
PIID HHSN272200900060C

Description of requirement

BIOMEDICAL (BASIC)

Dates and value

Award date
Signed on Aug 15, 2009
Potential end of performance
Aug 13, 2014
Current value
$79,361,174Base and exercised options
Potential value (if all options are exercised)
$100,958,063

Obligations by fiscal year of action

  • FY2017: -$7,805,323 (de-obligation)
  • FY2014: -$6,188,104 (de-obligation)
  • FY2013: $13,677,248
  • FY2012: $8,118,206
  • FY2010: $27,536,741
  • FY2009: $13,246,602

Total across 6 fiscal years: $48,585,370

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 15, 2017. View on USAspending · Recipient on SAM.gov

Recipient

LocationLEIDEN, NLD
UEIVRE2EKNJTJJ4
Business sizeOther than small businessSize at award, per the contracting officer

Business types and certifications

Foreign-ownedFor-profit organizationInternational organization

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Netherlands

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
35

Contract details

Subcontracting plan
Plan not requiredB
Major program
Application of platform technologies for the development of therapeutics for biodefense
Cost Accounting Standards clause
Yes - CAS clause includedY
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 15, 2009Base obligation at award: $13,246,602
Latest action
Sep 15, 2017 — Funding onlyModification 11; obligation change -$7,805,323; funding only: changes obligations, not scope
Latest substantive action
Sep 13, 2013 — Option exercisedModification 8; obligation change +$10,786,489
Latest funding action
Sep 15, 2017 — Funding onlyModification 11; obligation change -$7,805,323; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only6
  • Option exercised2
  • Other administrative action2
  • Supplemental agreement (within scope)1
12 actions recorded, Aug 15, 2009 to Sep 15, 2017; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$7,805,323
Latest action: change in base and all options
-$7,805,323

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
NetherlandsNLD
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
12

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2013/2013-0885-000
Object classes
  • 25.5: Research and development contracts